Staging rectal cancer: Endoscopic ultrasound and pelvic MRI

Cancer Imaging

Volumn 8, Issue SPEC. ISS. A, 2008, Pages

  Brown, Gina ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Endoscopic ultrasound; Pelvic MRI; Post operative treatment; Pre operative therapy; Rectal cancer

Indexed keywords

ARTICLE; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOSCOPIC ECHOGRAPHY; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROGNOSIS; RECTUM CANCER; RELIABILITY; RISK REDUCTION; SURGICAL ANATOMY;

ENDOSONOGRAPHY; HUMANS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RECTAL NEOPLASMS;

EID: 55149097924     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2008.9008     Document Type: Article

References (5)

1. Savides TJ, Master SS. EUS in rectal cancer. Gastrointest Endosc 2002; 56: S12-8.
2. Harada N, Hamada S, Kubo H, et al. Preoperative evaluation of submucosal invasive colorectal cancer using a 15-MHz ultrasound miniprobe. Endoscopy 2001; 33: 237-40.
3. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003; 90: 355-64.
4. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006; 333: 779.
5. Chau I, Brown G, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imagingdefined poor-risk rectal cancer. J Clin Oncol 2006; 24: 668-74.